# Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life

> **NCT02652676** · NA · TERMINATED · sponsor: **Loma Linda University** · enrollment: 4 (actual)

## Conditions studied

- Acute on Chronic Systolic Congestive Heart Failure

## Interventions

- **PROCEDURE:** Reversible Pulmonary Artery Banding
- **PROCEDURE:** GORE-TEX DualMesh EMERGE PLUS Biomaterial

## Key facts

- **NCT ID:** NCT02652676
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2021-05-07
- **Final completion:** 2021-05-07
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652676, "Reversible Pulmonary Artery Banding as Simplified Management of End-stage Dilated Left Ventriculopathy in Early Life". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02652676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*